Skip to content

Clinical trials

Hematologic Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Country / region: Poland Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20091
20111
20121
20141
20152
20172
20183
20216
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting10
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
Amgen1
Bristol-Myers Squibb1
CSL Behring1
Cogent Biosciences, Inc.1
Curis, Inc.1
European Society for Blood and Marrow Transplantation1
Kumquat Biosciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms24
Leukemia6
Lymphoma5
Multiple Myeloma5
Neoplasms5
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Non-Hodgkin4
Recurrence4
Hematologic Diseases3
Leukemia, Lymphocytic, Chronic, B-Cell3

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.